316
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

Co-delivery of paclitaxel and etoposide prodrug by human serum albumin and PLGA nanoparticles: synergistic cytotoxicity in brain tumour cells

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 246-262 | Received 28 Sep 2022, Accepted 06 Mar 2023, Published online: 17 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Syed Nazrin Ruhina Rahman, Abhinab Goswami, Aishwarya Jala, Animith Venuganti, Apurba Deka, Roshan M Borkar, Vivek Singh, Dipankar Das & Tamilvanan Shunmugaperumal. Studies on cationic ocular emulsions containing bipartitioned oil droplets to codeliver cyclosporin A and etodolac. Nanomedicine 0:0, pages 1-16.
Read now

Articles from other publishers (4)

Sonia Fathi-karkan, Rabia Arshad, Abbas Rahdar, Aghdas Ramezani, Razieh Behzadmehr, Suresh Ghotekar & Sadanand Pandey. (2023) Recent advancements in the targeted delivery of etoposide nanomedicine for cancer therapy: A comprehensive review. European Journal of Medicinal Chemistry 259, pages 115676.
Crossref
M. A. Merkulova, N. S. Osipova, A. V. Kalistratova, Yu. V. Ermolenko & S. E. Gel’perina. (2023) Etoposide-Loaded Colloidal Delivery Systems Based on Biodegradable Polymeric Carriers. Colloid Journal 85:5, pages 712-735.
Crossref
M. A. Merkulova, N. S. Osipova, A. V. Kalistratova, Yu. V. Ermolenko & S. E. Gel’perina. (2023) Etoposide-Loaded Colloidal Delivery Systems Based on Biodegradable Polymeric Carriers. Коллоидный журнал 85:5, pages 593-618.
Crossref
Xingyu Wang, Benoît Gigant, Xi Zheng & Qiang Chen. (2023) Microtubule‐targeting agents for cancer treatment: Seven binding sites and three strategies. MedComm – Oncology 2:3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.